NERV - Minerva Neurosciences, Inc.
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Annual
| Revenue | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 |
| Total Revenue | - | - | - | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | ||||
| Research Development | 30,255.892 | 20,439.994 | 18,533.363 | 42,908.566 |
| Selling General and Administrative | 10,914.269 | 9,750.702 | 7,576.256 | 11,961.865 |
| Non Recurring | - | - | - | - |
| Others | - | - | - | - |
| Total Operating Expenses | 41,170.161 | 30,190.696 | 26,109.619 | 54,870.431 |
| Operating Income or Loss | -41,170.161 | -30,190.696 | -26,109.619 | -54,870.431 |
| Income from Continuing Operations | ||||
| Total Other Income/Expenses Net | 270.682 | -854.676 | -972.013 | -2,031.008 |
| Earnings Before Interest and Taxes | -41,170.161 | -30,190.696 | -26,109.619 | -54,870.431 |
| Interest Expense | -614.264 | -1,029.734 | -1,053.07 | -2,049.735 |
| Income Before Tax | -40,899.479 | -31,045.372 | -27,081.632 | -56,901.439 |
| Income Tax Expense | -9,376.272 | - | - | - |
| Minority Interest | - | - | - | - |
| Net Income From Continuing Ops | -31,523.207 | -31,045.372 | -27,081.632 | -56,901.439 |
| Non-recurring Events | ||||
| Discontinued Operations | - | - | - | - |
| Extraordinary Items | - | - | - | - |
| Effect Of Accounting Changes | - | - | - | - |
| Other Items | - | - | - | - |
| Net Income | ||||
| Net Income | -31,523.207 | -31,045.372 | -27,081.632 | -56,901.439 |
| Preferred Stock And Other Adjustments | - | - | - | - |
| Net Income Applicable To Common Shares | -31,523.207 | -31,045.372 | -27,081.632 | -56,901.439 |
